US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector specializing in medical instruments and supplies, offers investors an intriguing opportunity with a potential upside..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Challenges with a Diverse Vaccine Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has generated considerable attention for its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge,..

Bio-Techne Corp (TECH) Stock Analysis: Potential 27.54% Upside Amidst Market Challenges

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector, specializes in biotechnology with a focus on life science reagents, instruments, and services. The Minneapolis-based..

Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential

Individual investors eyeing opportunities in the healthcare sector should consider Chemed Corp (CHE), a stalwart in the medical care facilities industry. With a substantial market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is capturing the attention of investors with its innovative approach in the diagnostics and research sector...

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a stalwart in the healthcare sector, offers a compelling investment opportunity for those looking to add a European pharmaceutical powerhouse to their portfolio...

Sanofi (SNY) Stock Analysis: Exploring an 18.53% Potential Upside in the Healthcare Sector

Sanofi (SNY), a French multinational pharmaceutical giant, is a significant player in the healthcare industry, particularly within the drug manufacturing sector. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 20% Upside Potential in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, is attracting investor attention due to its potential upside..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a Promising 40.78% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotech sector, not only for its innovative approach to tackling cancer but also for its impressive..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 54% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its promising focus on treating metabolic dysfunction-associated steatohepatitis (MASH)...

Royalty Pharma plc (RPRX): Investor Outlook with 11.57% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands at a pivotal position in the biotechnology sector, offering a unique investment opportunity through its innovative business model. As a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Solid Growth Prospects with a 2.91% Potential Upside

The Ensign Group, Inc. (ENSG) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry, where it has carved out a..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unveiling a 17% Upside Potential for Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is capturing attention in the biotechnology sector with a potential upside of 17.16%, as analysts project a promising future for this..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Fresenius Medical Care AG (FMS): Investor Outlook Reveals 17.34% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a global leader in dialysis services and products, stands as a noteworthy player in the healthcare sector, particularly within the..

HealthEquity, Inc. (HQY) Stock Analysis: Unveiling a 49.61% Upside Potential

Investors eyeing the healthcare sector may find HealthEquity, Inc. (NASDAQ: HQY) an intriguing proposition, given its robust service offerings and promising market position. Headquartered in Draper,..

Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside with Strong Buy Ratings

For investors seeking exposure to the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents an intriguing opportunity. With a market cap of $10.26 billion, this Netherlands-based company..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.78% Potential Upside in Healthcare

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is capturing investor attention with a robust market capitalization of $101.65 billion. The company, renowned..

Pfizer, Inc. (PFE) Stock Analysis: Navigating the Healthcare Giant’s Growth Potential Amidst a 6.22% Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a stalwart in the healthcare sector, renowned for its robust portfolio of biopharmaceutical products that cater to a wide range..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking Its 20.36% Potential Upside Amidst Mixed Financials

Avantor, Inc. (NYSE: AVTR) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, with its vast array of mission-critical products and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds